These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. Tolia V Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658 [TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity of salicylazosulfapyridine: a case report and review of the literature. Gulley RM; Mirza A; Kelly CE Am J Gastroenterol; 1979 Nov; 72(5):561-4. PubMed ID: 43669 [TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease. Schoonjans R; Mast A; Van den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W Am J Gastroenterol; 1993 Oct; 88(10):1759-63. PubMed ID: 8105680 [TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to salicylazosulfapyridine: renal and hepatic toxic reactions. Chester AC; Diamond LH; Schreiner GE Arch Intern Med; 1978 Jul; 138(7):1138-9. PubMed ID: 27155 [TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine. Adverse effects and desensitization. Taffet SL; Das KM Dig Dis Sci; 1983 Sep; 28(9):833-42. PubMed ID: 6136396 [No Abstract] [Full Text] [Related]
19. Leucopenia, thrombocytopenia and lymphadenopathy associated with sulphasalazine. McKenna KE; Burrows D Clin Exp Dermatol; 1994 Sep; 19(5):419-20. PubMed ID: 7955504 [TBL] [Abstract][Full Text] [Related]